Análisis del contenido de insulina inmunorreactiva y péptido C en casos de alteraciones de la tolerancia a la glucosa en familiares de pacientes con diabetes mellitus

Authors

  • P.S. Zavadsky ECIMED
  • A.G. Mazovetsky ECIMED

Abstract

Se determinó el contenido de insulina inmunorreactiva (IIR1 y péptido C inmunorreactivo (PCIR) durante una PTG oral, en familiares de pacientes con diabetes juvenil y en personas sanas. El contenido de PCIR era 2,5 a 5 veces más alto que el contenido de IIR. Las personas con resultados normales y dudosos de la PTG, tenían las curvas de la IIR y PCIR idénticas y se diferenciaban en las curvas de los pacientes con diabetes latente y manifiesta. La relación molar PCIR/IIR era diferente en los casos con resultados “patológicos” de la PTG en comparación con las normales.

Downloads

Download data is not yet available.

Downloads

Published

2020-10-19

How to Cite

1.
Zavadsky P, Mazovetsky A. Análisis del contenido de insulina inmunorreactiva y péptido C en casos de alteraciones de la tolerancia a la glucosa en familiares de pacientes con diabetes mellitus. Rev Cubana Med [Internet]. 2020 Oct. 19 [cited 2025 Feb. 12];20(2). Available from: https://revmedicina.sld.cu/index.php/med/article/view/1691

Issue

Vol. 20 No. 2 (1981)

Section

Original articles

License

The Cuban Journal of Medicine protects the author's patrimonial rights. However, it is licensed under a Creative Commons Licensehttps://creativecommons.org/licenses/by-nc/4.0/deed.es_ES which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided that the primary source of publication is duly cited. The author always retains his moral rights.

 

You are free to:

- Share - copy and redistribute the material in any medium or format.

- Adapt - remix, transform and build upon the material

- The license cannot revoke these freedoms as long as you follow the terms of the license.

Under the following terms:

- Attribution - You must give proper credit, provide a link to the license, and indicate if changes have been made. You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is supported by the licensor.

- Non-Commercial Purpose- You may not make use of the material for commercial purposes.

- No Additional Restrictions - You may not apply legal terms or technological measures that legally restrict others from making any use permitted by the license.